How We Work Together
I partner with MedTech, wearable, DTx, and SaMD leaders through flexible engagements designed for your specific challenges. Whether you need hands-on execution, fractional leadership, or strategic guidance through a critical sprint, I bring the same approach: get aligned, move fast, and make the right things happen.
ESTABLISHED COMPANIES & INVESTORS
Executive Strategy Intensive
Six weeks to strategic clarity and execution-ready direction.
​
This focused engagement helps leadership teams tackle a high-impact initiative whether that’s aligning a product roadmap with growth objectives, addressing stalled market traction, evaluating a U.S. market opportunity, or preparing for a relaunch or a raise. It’s built for companies navigating a strategic decision point and needing both clear direction and tangible outcomes.
​
Over six weeks, we:
-
Define the core strategic challenge or decision
-
Analyze product, market, and organizational context
-
Develop a focused, cross-functional plan
-
Deliver one polished strategic asset (e.g., roadmap brief, GTM plan, investor narrative)
-
Align your leadership team on priorities and next steps
Designed for: Companies navigating high-stakes growth decisions, the Executive Strategy Intensive brings the clarity, structure, and strategic direction needed to move with conviction.​
Strategic Execution Leadership
Bridge the gap between strategy and execution with embedded, executive-level leadership.
​
This engagement is designed for companies with a defined direction but limited internal capacity to lead it or for teams needing strategic refinement as they move into execution. Whether guiding a product from concept to commercialization, leading strategic fit assessments for add-on or portfolio-expanding acquisitions, or aligning operations around a critical initiative, Execution-Phase Leadership ensures key priorities are owned and advanced with focus and accountability.
​
How it works:
Weeks 1–2: Strategic and execution diagnostic - clarify initiative goals, identify gaps, map stakeholders
Month 1: Establish execution rhythm - team syncs, KPIs, accountability structure
Months 2–5: Lead cross-functional execution - vendor management, prioritization, real-time adjustments
Final Month: Handoff and sustain - document workflows, upskill internal leads, transition ownership
​
Ideal for:
-
Interim product or commercial leadership
-
Strategic initiative execution with light refinement
-
GTM or relaunch plan delivery
-
Scaling teams or prepping for investor milestones
-
Cross-functional projects requiring executive oversight
Timeline: Typically scoped as a 3–6 month engagement, with the option to extend for longer-term leadership support when needed.
Investor & Acquisition Strategy
Strategic clarity for better investment decisions and stronger post-deal outcomes.
​
This engagement supports investors, corporate strategy teams, and MedTech leaders preparing for or navigating M&A. Whether evaluating an acquisition target, stabilizing a portfolio company, or preparing your own company to be positioned for exit, this offering brings trusted product and commercial insight to high-stakes decisions.
​
How it works:
• Evaluate positioning: review strategy materials, regulatory fit, and market readiness
• Pressure-test the business case: validate GTM assumptions, product strategy, and investor narrative
• Support decision-making: outline red flags, key milestones, and integration risks
• Refine exit positioning: ensure messaging, metrics, and go-to-market story align with buyer expectations
​
Ideal for:
• Strategic and commercial due diligence
• Portfolio fit assessments and rollup planning
• US market entry evaluation for international companies
• Post-close repositioning and execution planning
• Exit preparation for founders and teams seeking to present effectively to acquirers
Timeline: Engagements are tailored based on need, ranging from short-term diligence projects to ongoing strategic advisory under retainer.
STARTUPS & EARLY STAGE
PRODUCT STRATEGY AUDIT
Know where you stand. Identify gaps. Get a clear path forward.
​
A rapid assessment of your product roadmap, regulatory pathway, and commercialization strategy. You'll get a written report identifying your biggest risks and specific recommendations to fix them before they cost you time and money.
​
Over 2-3 weeks, we:
-
Review product roadmap and technical approach
-
Assess regulatory pathway alignment and market positioning
-
Evaluate commercialization strategy and reimbursement fit
-
Analyze whether current development aligns with market realities
-
Deliver prioritized report identifying the 3-5 highest-risk gaps
Designed for:
Founders and early-stage companies navigating critical strategic decision points who need expert validation before investing significant resources.
Strategic Execution Leadership (CXO)
Strategic leadership that actually gets things done.
​
Embedded executive leadership that owns product strategy, commercialization planning, and execution. I step in as your CPO, CCO, or COO - bridging strategy and execution. You get the value of C-level experience driving your most critical initiatives forward without the cost of a full time employee.
​
How it works:
-
I become part of your leadership team, owning strategic initiatives you don't have bandwidth for
-
Equivalent to 1-2 days/week of strategic work, outcome-focused not hourly
-
Weekly or bi-weekly leadership sessions with ongoing availability between plus availability for time-sensitive decisions
-
I step in where you need me most: product strategy, commercialization, operations
-
Flexible scope that adapts as your company evolves and priorities shift
-
Deliver tangible outcomes: roadmaps, GTM plans, board materials, launch execution
​
Ideal for:
-
Companies with defined direction that need executive leadership to execute
-
Teams where the CEO needs strategic workload taken off their plate
-
Companies preparing for commercialization, launch, or major growth milestones
-
Organizations needing C-suite leadership without full-time commitment
​
Timeline: Ongoing engagement, renewable quarterly.
Limited Strategic Advisory
Expert strategic guidance without the execution commitment.
​
Regular strategy sessions to help you navigate strategy, product, regulatory, operational and/or commercialization decisions. I review your plans, challenge your thinking, connect you to the right resources
- but you and your team own the execution. It's strategic counsel, not hands-on leadership.
​
How it works:
-
Twice-monthly 90-minute strategy sessions
-
Document review and strategic feedback between sessions
-
Access to my network and 25+ years of MedTech expertise
-
Quarterly commitment with option to renew
Ideal for:
-
Founders who want an experienced strategic advisor in their corner
-
Teams navigating regulatory strategy, product-market fit, or commercialization planning
-
Companies that need strategic support but have execution capacity internally
-
Leadership teams making high-stakes decisions who want expert validation
Timeline: Ongoing engagement, renewable quarterly.
Most clients stay engaged for 6-12 months as they move through key development and commercialization milestones and upgrade to CXO fractional support once more significant funding comes through.
